IL-23 and its receptor; related reagents and methods
Details for Australian Patent Application No. 2004293811 (hide)
International Classifications
Event Publications
25 May 2006 PCT application entered the National Phase
PCT publication WO2005/052157 Priority application(s): WO2005/052157
6 January 2011 Application Accepted
Published as AU-B-2004293811
12 May 2011 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2005
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser